Swedish Orphan International Overview

  • Founded
  • 1988

Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 51

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Swedish Orphan International General Information

Description

Provider of human leukocyte derived interferon and related drugs. The company specializes in the development, marketing and distribution of pharmaceutical products, focusing on orphan drugs (niche products) with unmet medical needs that can be used in the treatment of rare disorders and life-threatening diseases.

Contact Information

Website
www.swedishorphan.com
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Distributors (Healthcare)
Acquirer
Swedish Orphan Biovitrum
Primary Office
  • 112 76 Stockholm
  • Sweden
+46 08-697 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Swedish Orphan International Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Swedish Orphan International‘s full profile, request access.

Request a free trial

Swedish Orphan International Patents

  • 17

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Swedish Orphan International Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2136200-A Modification of interferon alpha production Inactive 29-Dec-1998 000000000
CA-2354025-A1 Modification of interferon alpha production Active 29-Dec-1998 000000000
CA-2354025-C Modification of interferon alpha production Inactive 29-Dec-1998 000000000
DE-69926013-T2 Changing the preparation of alpha interferon Inactive 29-Dec-1998 000000000
DE-69926013-D1 Changing the preparation of alpha interferon Inactive 29-Dec-1998 C07K14/56
To view Swedish Orphan International’s complete patent history, request access »

Swedish Orphan International Executive Team (1)

Name Title Board Seat Contact Info
Bo Jesper Hansen Ph.D Chief Executive Officer
To view Swedish Orphan International’s complete executive team members history, request access »

Swedish Orphan International Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Swedish Orphan International Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Swedish Orphan International‘s full profile, request access.

Request a free trial